Accelerating Evidence-based Action for Every Family Everywhere LAUNCH: WHO’s Full Value of Vaccines Assessment Report
Wednesday 3rd November from 2 pm (free to attend virtually online), Time Zone London, UK (GMT)
Hosted by The London School of Hygiene & Tropical Medicine
Worldwide over 20 million pregnant women are estimated to be affected by Group B Streptococcal infection. To date, most focus has been on infections in children, yet there are many additional consequences for women themselves, including stillbirths, preterm birth and long-term impacts for affected survivors. The WHO-led Value Case Proposition includes years of work by many teams from all over the world on new data, analysis regarding long-term health and economic consequences of GBS disease, and estimated costs/benefits of vaccination or other prevention approaches. The report findings will be relevant for families, policymakers, clinicians, scientists, & industry. There will be a particular spotlight on meningitis and this Report is linked to the WHO Global Roadmap to Defeat Meningitis by 2030.
Full agenda below.
Welcome with Dr Kim Eva Dickson (UNICEF) - MC
Dr Tedros Adhanom Ghebreyesus - Director-General of the World Health Organization
Dr Philipp Lambach, WHO
With Prof Joy Lawn, Director of the MARCH Centre, London School of Hygiene and Tropical Medicine
Prof Mark Jit, London School of Hygiene and Tropical Medicine
Dr Philipp Lambach (WHO), Prof Joy Lawn, (LSHTM), Prof Mark Jit (LSHTM)
Welcome back with Dr Kim Eva Dickson (UNICEF)
Dr Kate O’Brien, Director of the Department of Immunization, Vaccines and Biological (WHO)
Pfizer, Dr Martina Baye (Government of Cameroon), Dr Marta Tufet, Head of Policy (GAVI), Dr Kim Eva Dickson (UNICEF), Dr Ajoke Sobanjo – Ter Meulen (Bill & Melinda Gates Foundation)
Dr Marie-Pierre Preziosi (WHO), Vinny Smith (CEO of Meningitis Research Foundation), Prof Beate Kampmann, Director of The Vaccine Centre at the London School of Hygiene and Tropical Medicine
Close of Day